Tiziana Life Sciences (TLSA)
(Delayed Data from NSDQ)
$1.02 USD
-0.09 (-7.81%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.03 +0.01 (0.98%) 6:02 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.02 USD
-0.09 (-7.81%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $1.03 +0.01 (0.98%) 6:02 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Buy Tesla Stock for Humanoid Robots and Full-Self Driving?
by David Bartosiak
Tesla's last earnings call sounded like a sci-fi novel but does the stock's chart signal a buy?
Precision (DTIL) Inks Deal With Tiziana for Cancer Candidate
by Zacks Equity Research
Precision (DTIL) signs an exclusive license agreement with Tiziana to explore the latter's fully human anti-CD3 mAb, foralumab, for treating various cancer indications. Stock up.
Tiziana (TLSA) Posts Positive Data on Nasal COVID-19 Antibody
by Zacks Equity Research
Tiziana (TLSA) reports positive data from a study investigating its anti-CD3 human monoclonal antibody, foralumab (nasally administered) for treating COVID-19 patients in Brazil. Shares up.
Tiziana Life's (TLSA) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Tiziana Life Sciences (TLSA).
Repligen (RGEN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Repligen (RGEN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Tiziana Life Sciences PLC (TLSA) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Tiziana Life Sciences PLC (TLSA).
Find Strong-Buy Stocks with this Filtered Zacks Rank 5 Screen
by Benjamin Rains
Today we showcased how to add two relatively simple filters to our Zacks Rank #1 criteria in order to narrow down the number of stocks and try to increase performance with our Filtered Zacks Rank 5 Screener...
Company News for Jun 30, 2020
by Zacks Equity Research
Companies in the news are: KNSA, TLSA, COTY, ICPT
Company News for Mar 12, 2020
by Zacks Equity Research
Companies In The News Are: TLSA, VIR, HEAR, CDMO
Company News for Jan 10, 2020
by Zacks Equity Research
Companies In The News Are:
3 Blue-Chip Tech Stocks to Buy for 2020
by Benjamin Rains
We found three blue-chip technology stocks, with the help of our Zacks Stock Screener, that investors might want to buy for 2020...
Buy Disney Stock for 2020 on Streaming TV Success Against Netflix?
by Benjamin Rains
Should investors buy Disney (DIS) stock for 2020 on streaming TV success against Netflix?